bee venom: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
bee venom: clinical details
Prescribing considerations
- Confirm a compatible systemic clinical history and demonstrable IgE sensitisation to Apis mellifera.
- Ensure specialist supervision, immediate access to resuscitation facilities and staff trained to treat anaphylaxis.
- Assess cardiovascular disease, autoimmune disease, malignancy, mastocytosis or raised baseline tryptase, asthma control and renal function.
- Review previous reactions, current health, allergy status and medication changes before each injection.
- Use particular care when assessing young children because efficacy evidence is limited.
Contraindications and cautions
- Hypersensitivity to an excipient
- Active or poorly controlled systemic autoimmune disease or an immunodeficiency disorder
- A condition in which induced anaphylaxis would present an unacceptable risk, such as severe cardiovascular disease
- Asthma at risk of exacerbation or with inadequate symptom control
Monitoring
- Assess asthma control before every injection.
- Observe after administration and record immediate local or systemic reactions.
- Ask about delayed reactions before subsequent injections.
- Monitor patients with mastocytosis or raised baseline tryptase particularly carefully.
- Reassess benefit and risk after a large local reaction or any systemic reaction.
Clinical pharmacology
Honey-bee venom allergen is adsorbed to hydrated aluminium hydroxide for slow release after subcutaneous injection. Immunotherapy shifts allergen responses away from Th2 activity, increases regulatory signalling and blocking IgG, and reduces basophil histamine release.
Formulation and product differences
- The maintenance product is an aluminium-hydroxide-adsorbed suspension for subcutaneous injection supplied as a red-coded maintenance vial.
- A pale precipitate may form during storage and should be gently resuspended before inspection and use.
- It is not interchangeable with other venom-immunotherapy products and must not be mixed with other medicines.
- Store refrigerated and protected from light; do not freeze.
bee venom interactions
Give the allergy team a complete list of prescribed, over-the-counter and complementary treatments.
ACE inhibitors
They may increase the severity of anaphylaxis and might reduce the immunotherapy response, so individual review and closer monitoring may be needed.
Beta-blockers
They can reduce the response to adrenaline used for anaphylaxis and require careful risk assessment.
Tricyclic antidepressants, monoamine oxidase inhibitors and COMT inhibitors
They may dangerously intensify the cardiovascular effects of adrenaline used during an emergency.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.